https://www.fiercebiotech.com/medtech/intervenn-biosciences-quintuples-funding-201m-for-ai-powered-cancer-tests
InterVenn Biosciences quintuples funding with $201M for AI-powered cancer tests | Fierce Biotech
Aug 2, 2021 - In recent years, startups using artificial intelligence to develop liquid biopsy tests for cancer have attracted large hauls of medtech venture capital.
https://intervenn.com/
InterVenn Biosciences
biosciences